New patent expiration for Merck Sharp drug DUTREBIS

   April 3, 2024    Comments Off on New patent expiration for Merck Sharp drug DUTREBIS    Posted in: Uncategorized

Annual Drug Patent Expirations for DUTREBIS Dutrebis is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are two patents protecting this drug. The generic…
Source

Continue reading

New patent expiration for Msd Sub drug ISENTRESS

   April 3, 2024    Comments Off on New patent expiration for Msd Sub drug ISENTRESS    Posted in: Uncategorized

Annual Drug Patent Expirations for ISENTRESS Isentress is a drug marketed by Msd Sub Merck and is included in three NDAs. It is available from nine suppliers. There are six…
Source

Continue reading
Biotechblog